Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome

NCT05306080 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

CRS - Cytokine Release Syndrome
HLH

Interventions

DRUG: Tadekinig alfa (IL-18BP)

Sponsor

University of Pennsylvania